Study of the Effects of Intravenous Exenatide on Cardiac Repolarization
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
Two-Part, Randomized, Placebo and Active-Controlled, Double-Blind, Thorough QT Study
Evaluating the Effects of Intravenous Exenatide on Cardiac Repolarization in Healthy Male and
Female Volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Intarcia Therapeutics
Treatments:
Exenatide Moxifloxacin Norgestimate, ethinyl estradiol drug combination Palonosetron